Efficacy of dupilumab in children with uncontrolled, moderate-to-severe type 2 asthma, with/without evidence of allergic asthma: the VOYAGE phase 3 study 

Efficacy of dupilumab in children with uncontrolled, moderate-to-severe type 2 asthma, with/without evidence of allergic asthma: the VOYAGE phase 3 study